Hypoglycaemic activity of drugs, including the products instead of conventionally used albino rabbits, and their derived from medicinal plants, is conventionally assessed in suitability for serving as experimental animal models for diabetic animal models by observing drug-induced fall in the above stated purpose was evaluated. Sub-optimal fasting blood glucose (FBG) or suppression of glucose doses of alloxan were injected intravenously for inducing tolerance curve. Diabetes is induced experimentally by beta cell destruction partially. The course of partial or total pancreatectomy, exposure to antiislet cell hyperglycaemic state was carefully monitored and changes antibodies, but most commonly by injecting chemical agents, in body weight recorded. It was observed that the low such as alloxan or streptozotocin, that cause widespread dose alloxanated Angora rabbits showed increased destruction of insulin-secreting pancreatic beta cells 1 .
feeding behaviour, gained weight rapidly, leading to However, beta cells being extensively eliminated/or moderate obesity, and developed impairment of glucose destroyed in the diabetic animals, several drugs that require tolerance, though FBG remained near normal. Utility of functional pancreas cannot be satisfactorily tested in them.
these animals -moderately obese with mild glucose intolerance -for detecting the mild hypoglycaemic Moreover, the drug-induced fall in FBG as a criterion for hypoglycaemic effect has been reported to be a relatively insensitive method of assessment and sometimes gives inconsistent results
2
. Post-treatment suppression of glucose tolerance curve, though a sensitive method of assessment, suffers from a major drawback in that the test is associated with high mortality in diabetic animals 3 . Need for better animal model for screening hypoglycaemic activity of compounds has therefore being felt; hence the present study carried out in British Angora rabbits, activity of leaf extract of Biophytum sensitivum, a Nepalese herb 4 , has been evaluated and discussed in this paper. A standard hypoglycaemic drug, tolbutamide, was taken for reference.
MATERIALS AND METHODS
Alloxan monohydrate was purchased from Sigma. Tolbutamide (Hoechst Pharmaceuticals) was obtained locally. Inbred male British Angora rabbits of body weight 700 to 1000 g and age 2.0-2.5 mo were purchased from Palkhibas farm, located in mountainous Dhankuta district in Eastern Nepal. Permission for conducting experiments on these animals was granted by the www.ijpsonline.com research committee of B. P. Koirala Institute of Health Sciences, where the study was carried out, as also by Nepal Health Research Council. Having been brought down from high altitude to foothills, the animals were acclimatized to laboratory conditions and handling for at least 2 w, during which period they were given pallet diet obtained from of Hindustan Lever Ltd., Mumbai. Oral glucose tolerance test was performed in them to rule out diabetes and other forms of carbohydrate intolerance. Blood samples were collected from the marginal ear vein.
doses of 70 mg/kg-and 60 mg/kg-body weight of alloxan were also given to the separate groups of animals for inducing diabetes of milder severity course of diabetes following alloxanization was monitored, as described in the next section. It may be mentioned presently that FBG initially rose in all alloxanated rabbits. In most, the hyperglycaemic state stabilized, resulting in overt diabetes; whereas in some others, initial high FBG levels returned to near normal after few days. The latter group of rabbits developed moderate obesity as well and showed impairment of glucose tolerance; they were designated as obese Plant material:
glucose-intolerant (OGI) rabbits. Samples of the Biophytum sensitivum (family Oxalidaceae; Accession No. 199600026), a traditional antidiabetic herb, Four rabbits, which did not show any increase in FBG were obtained from the Botany Department, Mohender levels even initially after alloxanization, were considered Morang Campus (Postgraduate Institute, Biratnagar), for totally resistant and were excluded from the study. this study. With the help of these samples, our field workers were trained so as to be able to study its Assessment of hypoglycaemic effect: morphology to avoid any mistake during collection from Ability of a compound to lower the FBG or attenuate the the thick Tarahara forests. The plant was then collected glucose tolerance curve is conventionally taken to be an from these forests (Sunsari district), on the eastern bank indicator of its hypoglycaemic effect, as mentioned of Koshi River, during the months of August to October earlier. In OGI rabbits, FBG being normal, suppression of 1997, the time when it grows in abundance. For reliable glucose tolerance test (GTT) only was taken into identification, the new plant samples were sent to the consideration. Five to seven days before the Botany Department of the above institute, where they commencement of the experiment, GTT was performed were authenticated.
in these animals following an overnight fast. Fasting blood sample was taken, glucose was orally administered at a The plant leaves were separated, dried, soaked in water dose of 3 g/kg body weight and then plasma glucose was for about 16 h and homogenized. The homogenate was estimated in blood samples drawn 1 h, 2 h and 3 h later centrifuged at 3000 g for 15 min. The supernatant was from marginal ear vein. The GTT curve was drawn and decanted, filtered and the extract so obtained was area under curve (AUC) calculated, which not only separated and used for the present study. The above confirmed hyperglycaemic status of the animal but also process yielded 13.2% w/w extract, as reported by us showed the pre-treatment base-line glucose tolerance earlier 5 . It was orally administered to the experimental pattern. One week later, the test (GTT) was repeated animals, using feeding tube (No. 7).
following administration of the test compound orally and 90 min later, oral glucose load was given at the above Biochemical estimations: Blood glucose level was estimated by glucose-oxidase/ peroxidase method 6 , using kits from Ranbaxy, Delhi. Insulin was estimated in sera by ELISA technique using commercial kits from Immunosystems, Italy.
Induction of alloxan diabetes:
Overnight fasted rabbits were rendered diabetic by single intravenous injection of alloxan monohydrate at a dose of 80 mg/kg body weight, which was found to be the optimum dose for the induction of diabetes in our earlier study 7 . Serum glucose level was checked after 72 h of alloxanization, and the animals with glucose level exceeding 200 mg% were considered diabetic. Lower dose. Blood samples were collected before the administration of glucose and 1 h, 2 h and 3 h later. The corresponding pre-treatment and post-treatment glucose levels at these three points of time and the AUCs were compared to assess post-treatment suppression of the curve, if any, which would reflect hypoglycaemic activity of the test compound.
In contrast to OGI, in overt diabetic rabbits both fall of FBG and attenuation of GTT were taken as criteria of hypoglycaemic effect. However, GTT was associated with high mortality in the diabetic rabbits and therefore generally avoided in those having severe hyperglycaemia (FBG > 250 mg/dl). www.ijpsonline.com
RESULTS AND DISCUSSION
mg/kg alloxan, the FBG predictably rose initially till about week but showed a spontaneous reversal after article. Their mean body weight was significantly higher than the animals of the control group, but fasting blood animals in fasted state ( Table 2 . It may be observed that mild hypoinsulinaemia and impaired glucose-induced unlike diabetic animals, they did not exhibit any significant insulin response is seen in the OGI animals, which hyperglycaemia or hypoinsulinaemia.
suggests that the pancreatic beta cells were partially damaged by sub-optimal dose of alloxan. This primarily Reversal of experimental diabetic state, as seen in OGI accounts for the impaired glucose tolerance pattern animals in our study, has been reported in rats, mice and observed, though obesity may accentuate glucose rabbits in earlier studies 2, 8 . Abnormalities of glucose intolerance by diminishing responsiveness of the target metabolism and dyslipidaemias were also observed in cells to insulin. Further studies, including histopathological those animals. In view of this, the alloxanated animals examination and receptor analysis, are necessary to showing apparent reversal of diabetes in the present validate the latter point. Abnormality of the glucose study (i.e., the OGI rabbits) were tested for any tolerance pattern as described above was reproducible abnormality of glucose metabolism by glucose tolerance even after 4 mo of alloxanization, suggesting development test. Greater elevations of blood glucose at 1, 2 and 3 h of a stable subdiabetic state. were observed in OGI rabbits compared to corresponding values in the control rabbits ( fig. 1) . The Activity of the Biophytum sensitivum leaf extract was area under curve in the OGI rabbits, 635.8 mg/dl/h, was tested by oral administration of the extract at optimum also higher than that for the control rabbits (394.2 mg/dl/ dose of 200 mg/kg following an overnight fast 7 , recording h), suggesting that the OGI rabbits are not able to the glucose tolerance pattern and comparing it with the prevent elevation of blood glucose levels following pattern observed before the treatment. Consistent glucose load. Serum insulin levels were lower in these reductions in blood glucose levels were observed at all 213±9  218±12  260±16  288±16  292±15  282±14  296±20  70  86±7  126±8  212±10  210±11  252±11  232±11  208±11  216±12  60  84±6  110±9  168±9  206±10  180±9  102±6  88±7  96±6 Blood glucose values expressed as mg/dl and dose of alloxan as mg/kg body weight. The fasting blood glucose levels were recorded at 5 days' interval up to 35 days after alloxan treatment for following course of diabetes fig. 1 ), which were significantly lower than the corresponding pre-treatment levels. The AUC in the treated animals (473.6 mg/dl/h) showed a significant fall of 25.6% compared to the pre-treatment value of 635.8 mg/dl/ h. Activity of tolbutamide, a standard oral hypoglycaemic agent, was also tested in the OGI model. At a dose of 500 mg/kg, tolbutamide caused improvement in the glucose tolerance pattern and significantly reduced the AUC to 411.8 mg/dl/h (P < 0.01) compared to the corresponding pre-treatment AUC, thereby ensuring that the OGI model responds to a known standard drug as well.
In diabetic rabbits, elevations of both FBG and glucose tolerance curve occur; therefore, the hypoglycaemic activity was judged by taking into consideration the post treatment fall of FBG as well as suppression of glucose tolerance curve. Following administration of the leaf extract, FBG showed marginal alterations at 1 h, 2 h and 6 h ( fig. 2 ). Compared to the corresponding values in the untreated diabetic rabbits, these values were slightly lower but not significantly. Similar trend was observed in the glucose tolerance pattern when the pre-treatment pattern was compared to the post-treatment pattern to look for evidence of suppression, if any (Table 3) . Decreases in the 1 h, 2 h and 3 h blood glucose values were small, insignificant and rather inconsistent -the inconsistency and variability of response of these animals being reflected by large standard deviations. Fall in AUC in the treated animals compared to the pre-treated animals (865 to 849 mg/dl/h) was also marginal (1.9%) and insignificant. It is noteworthy that single administration of the same dose of plant extract had produced significant fall of the glucose tolerance curve in OGI rabbits ( fig. 1 ) but failed to elicit such effect in diabetic rabbits. Likewise, tolbutamide treatment led to inconclusive results in FBG ( fig. 2 ) and GTT pattern of the diabetic rabbits (results not shown), though it had elicited pronounced hypoglycaemic effect in OGI rabbits. Thus the diabetic animals as animal models are not as sensitive for assessing hypoglycaemic activity of test compounds as the OGI rabbits. This is explained by the fact that extensive damage of pancreatic beta cells in diabetic animals limits their utility for assessing hypoglycaemic potential of the test compounds that require functional pancreas, such as the plant leaf extract, which has earlier been shown to act by inducing secretion of insulin from the pancreatic beta cells 7 . An additional limiting factor in use of diabetic animals is that GTT resulted in high mortality in them, whereas no such problem was encountered in OGI rabbits.
Taken together, these observations in the OGI and the overt diabetic rabbits suggest that the OGI model is more sensitive in detecting mild hypoglycaemic activity of a crude extract. The crude extracts generally interfere less with the regulatory mechanisms involved in carbohydrate metabolism, and their use causes significantly less hypoglycaemic effect compared to more potent synthetic drugs 9 . Such mild hypoglycaemic effect was missed by www.ijpsonline.com same animal serves as its own control because the blood glucose values within the same group of animals were compared before and after treatment. This results in minimizing the biological variations, which provides additional advantage of enhancing reliability of the results. In view of these results, it is hoped that OGI rabbits would serve as a useful experimental tool for screening crude extracts with slight activity, thereby successfully putting to test hypoglycaemic potential of plant products. Though recently, sophisticated animal models [e.g., BioBreeding (BB) rat, nonobese diabetic (NOD) mouse, the plant extract, which is active at lower dose.
